Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

OtherReview Articles

Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema

W.S. Bartynski
American Journal of Neuroradiology June 2008, 29 (6) 1043-1049; DOI: https://doi.org/10.3174/ajnr.A0929
W.S. Bartynski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

References

  1. ↵
    Dinsdale HB. Hypertensive encephalopathy. Neurol Clin 1983;1:3–16
    PubMed
  2. Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165:627–31
    CrossRefPubMedWeb of Science
  3. ↵
    Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992;159:379–83
    CrossRefPubMedWeb of Science
  4. ↵
    Strandgaard S, Olesen J, Skinhoj E, et al. Autoregulation of brain circulation in severe arterial hypertension. BMJ 1973;1:507–10
    Abstract/FREE Full Text
  5. ↵
    Guyton AC. Cerebral blood flow, cerebrospinal fluid and brain metabolism. In: Gutyton AC, ed. Textbook of Medical Physiology. 11th ed. Philadelphia: Elsevier Saunders;2006 :761–68
  6. ↵
    Zwienenberg-Lee M, Muizelaar JP. Clinical pathophysiology of traumatic brain injury. In: HR W, ed. Youmans Neurological Surgery. 5th ed. Philadelphia: Saunders;2004 :5039–64
  7. ↵
    Langfitt TW, Obrist WD. Occlusive cerebrovascular disease. In: Wilkins RH, Rengachary SS, eds. Neurosurgery. New York: McGraw-Hill;1985 :1167–73
  8. ↵
    Auer LM. The pathogenesis of hypertensive encephalopathy: experimental data and their clinical relevance with special reference to neurosurgical patients. Acta Neurochir Suppl (Wien) 1978;27:1–111
    PubMed
  9. ↵
    Kontos HA, Wei EP, Navari RM, et al. Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol 1978;234:H371–83
    PubMedWeb of Science
  10. ↵
    MacKenzie ET, Strandgaard S, Graham DI, et al. Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier. Circ Res 1976;39:33–41
    Abstract/FREE Full Text
  11. ↵
    Kalimo H, Kaste M, Haltia M. Vascular diseases. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology. 7th ed. New York: Oxford University Press;2002 :281–356
  12. ↵
    Kaplan NM. Management of hypertensive emergencies. Lancet 1994;344:1335–38
    CrossRefPubMedWeb of Science
  13. ↵
    Servillo G, Bifulco F, De Robertis E, et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 2007;33:230–36
    CrossRefPubMedWeb of Science
  14. ↵
    Striano P, Striano S, Tortora F, et al. Clinical spectrum and critical care management of posterior reversible encephalopathy syndrome (PRES). Med Sci Monit 2005;11:CR549–53
    PubMedWeb of Science
  15. ↵
    Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001;24:361–64
    PubMed
  16. Rail DL, Perkin GD. Computerized tomographic appearance of hypertensive encephalopathy. Arch Neurol 1980;37:310–11
    CrossRefPubMedWeb of Science
  17. Weingarten K, Barbut D, Filippi C, et al. Acute hypertensive encephalopathy: findings on spin-echo and gradient-echo MR imaging. AJR Am J Roentgenol 1994;162:665–70
    CrossRefPubMedWeb of Science
  18. ↵
    Weingarten KL, Zimmerman RD, Pinto RS, et al. Computed tomographic changes of hypertensive encephalopathy. AJNR Am J Neuroradiol 1985;6:395–98
    Abstract/FREE Full Text
  19. ↵
    Apollon KM, Robinson JN, Schwartz RB, et al. Cortical blindness in severe preeclampsia: computed tomography, magnetic resonance imaging, and single-photon-emission computed tomography findings. Obstet Gynecol 2000;95:1017–19
    CrossRefPubMedWeb of Science
  20. ↵
    Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome (PRES). AJNR Am J Neuroradiol 2007;28:1320–27
    Abstract/FREE Full Text
  21. ↵
    Bartynski WS, Zeigler Z, Spearman MP, et al. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol 2001;22:1901–14
    Abstract/FREE Full Text
  22. ↵
    Sibai BM. Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990;163:1049–54, discussion 1054–55
    CrossRefPubMedWeb of Science
  23. ↵
    Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008 Mar 20 [Epub ahead of print]
  24. ↵
    Bartynski WS, Boardman JF. Catheter angiography, MR angiography and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2008;29:447–55
    Abstract/FREE Full Text
  25. ↵
    Bartynski WS, Zeigler ZR, Shadduck RK, et al. Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. AJNR Am J Neuroradiol 2004;25:261–69
    Abstract/FREE Full Text
  26. ↵
    Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500
    CrossRefPubMedWeb of Science
  27. Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001;219:756–65
    CrossRefPubMedWeb of Science
  28. ↵
    Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991;8:393–401
    PubMedWeb of Science
  29. ↵
    Mark AL. Cyclosporine, sympathetic activity, and hypertension. N Engl J Med 1990;323:748–50
    PubMedWeb of Science
  30. ↵
    Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990;323:693–99
    CrossRefPubMedWeb of Science
  31. ↵
    Brubaker LM, Smith JK, Lee YZ, et al. Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging. AJNR Am J Neuroradiol 2005;26:825–30
    Abstract/FREE Full Text
  32. ↵
    Engelter ST, Petrella JR, Alberts MJ, et al. Assessment of cerebral microcirculation in a patient with hypertensive encephalopathy using MR perfusion imaging. AJR Am J Roentgenol 1999;173:1491–93
    PubMed
  33. ↵
    Naidu K, Moodley J, Corr P, et al. Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br J Obstet Gynaecol 1997;104:1165–72
    PubMedWeb of Science
  34. ↵
    Camargo EE. Brain SPECT in neurology and psychiatry. J Nucl Med 2001;42:611–23
    Abstract/FREE Full Text
  35. ↵
    Hypertensive disorders of pregnancy. In: Cunningham FG, Gant NF, Leveno KJ, et al, eds. Williams Obstetrics. 21st ed. New York: McGraw Hill;2001 :567–618
  36. ↵
    Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179:1359–75
    CrossRefPubMedWeb of Science
  37. ↵
    Bartynski WS, Boardman JF, Zeigler ZR, et al. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006;27:2179–90
    Abstract/FREE Full Text
  38. ↵
    Bartynski WS, Tan HP, Boardman JF, et al. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 2008;29:924–30
    Abstract/FREE Full Text
  39. ↵
    Coughlin WF, McMurdo SK, Reeves T. MR imaging of postpartum cortical blindness. J Comput Assist Tomogr 1989;13:572–76
    PubMedWeb of Science
  40. ↵
    Trommer BL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke 1988;19:326–29
    Abstract/FREE Full Text
  41. ↵
    Toole JF. Lacunar syndromes and hypertensive encephalopathy. In: Toole JF, ed. Cerebrovascular Disorders. 5th ed. New York: Raven;1999 :342–55
  42. ↵
    Shimono T, Miki Y, Toyoda H, et al. MR imaging with quantitative diffusion mapping of tacrolimus-induced neurotoxicity in organ transplant patients. Eur Radiol 2003;13:986–93
    PubMedWeb of Science
  43. ↵
    Maemura K, Kurihara H, Morita T, et al. Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury. Gerontology 1992;38(suppl 1):29–35
  44. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992;6:2591–99
    Abstract
  45. ↵
    Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am J Physiol 1992;262:C854–61
    PubMedWeb of Science
  46. ↵
    Geraghty JJ, Hoch DB, Robert ME, et al. Fatal puerperal cerebral vasospasm and stroke in a young woman. Neurology 1991;41:1145–47
    Abstract/FREE Full Text
  47. ↵
    Lewis LK, Hinshaw DB Jr, Will AD, et al. CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology 1988;30:59–64
    CrossRefPubMedWeb of Science
  48. ↵
    Belfort MA, Saade GR, Grunewald C, et al. Association of cerebral perfusion pressure with headache in women with pre-eclampsia. Br J Obstet Gynaecol 1999;106:814–21
    PubMedWeb of Science
  49. Qureshi AI, Frankel MR, Ottenlips JR, et al. Cerebral hemodynamics in preeclampsia and eclampsia. Arch Neurol 1996;53:1226–31
    CrossRefPubMedWeb of Science
  50. ↵
    Williams KP, Wilson S. Persistence of cerebral hemodynamic changes in patients with eclampsia: a report of three cases. Am J Obstet Gynecol 1999;181:1162–65
    CrossRefPubMedWeb of Science
  51. ↵
    The placenta and fetal membranes. In: Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD, eds. Williams Obstetrics. 21st ed. New York: McGraw Hill;2001 :85–108
  52. ↵
    Hill GR, Crawford JM, Cooke KR, et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997;90:3204–13
    Abstract/FREE Full Text
  53. ↵
    Antin JH, Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992;80:2964–68
    Abstract/FREE Full Text
  54. Bartynski WS, Zeigler ZR, Shadduck RK, et al. Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation. Neurocrit Care 2005;3:33–45
    CrossRefPubMed
  55. ↵
    Ferrara JL. Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. J Hematother Stem Cell Res 2000;9:299–306
    CrossRefPubMed
  56. Holler E, Kolb HJ, Moller A, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990;75:1011–16
    Abstract/FREE Full Text
  57. ↵
    Schots R, Kaufman L, Van Riet I, et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia 2003;17:1150–56
    CrossRefPubMed
  58. ↵
    Zeigler ZR, Rosenfeld CS, Andrews DF 3rd, et al. Plasma von Willebrand factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM). Am J Hematol 1996;53:213–20
    CrossRefPubMedWeb of Science
  59. ↵
    Ramanathan V, Helderman JH. Cyclosporine formulations. In: Sayegh M, Remuzzi G, eds. Current and Future Immunosuppressive Therapies Following Transplantation. The Netherlands: Kluwer Academic;2001 :111–21
  60. ↵
    Shapiro R. Tacrolimus. In: Sayegh M, Remuzzi G, eds. Current and Future Immunosuppressive Therapies Following Transplantation. The Netherlands: Kluwer Academic;2001 :123–42
  61. ↵
    Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989;73:2018–24
    Abstract/FREE Full Text
  62. ↵
    Kon V, Sugiura M, Inagami T, et al. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990;37:1487–91
    PubMedWeb of Science
  63. ↵
    Rouquette-Gally AM, Boyeldieu D, Gluckman E, et al. Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren syndrome and scleroderma. Br J Haematol 1987;66:45–47
    PubMedWeb of Science
  64. ↵
    Munford RS. Sepsis, severe sepsis and septic shock. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Disease. Philadelphia: Elsevier;2005 :906–26
  65. Varon J, Marik PE. Multiple organ dysfunction syndrome. In: Irwin RS, Rippe JM, eds. Irwin and Rippe's Intensive Care Medicine. 5th ed. Philadelphia: Lippincott-Williams & Wilkins;2003 :1834–38
  66. ↵
    Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707–10
    CrossRefPubMedWeb of Science
  67. ↵
    Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448–54
    CrossRefPubMedWeb of Science
  68. ↵
    McGuire TR, Bociek GR, Pavletic SZ, et al. Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations. Bone Marrow Transplant 2001;28:889–93
    CrossRefPubMed
  69. ↵
    Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003;101:3765–77
    Abstract/FREE Full Text
  70. Mutunga M, Fulton B, Bullock R, et al. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 2001;163:195–200
    CrossRefPubMedWeb of Science
  71. ↵
    Parent C, Eichacker PQ. Neutrophil and endothelial cell interactions in sepsis: the role of adhesion molecules. Infect Dis Clin North Am 1999;13:427–47, x
    CrossRefPubMedWeb of Science
  72. ↵
    McCuskey RS, Urbaschek R, Urbaschek B. The microcirculation during endotoxemia. Cardiovasc Res 1996;32:752–63
    Abstract/FREE Full Text
  73. ↵
    Symeonides S, Balk RA. Nitric oxide in the pathogenesis of sepsis. Infect Dis Clin North Am 1999;13:449–63, x
    CrossRefPubMedWeb of Science
  74. ↵
    Sands KE, Bates DW, Lanken PN, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997;278:234–40
    CrossRefPubMedWeb of Science
  75. ↵
    Wanecek M, Weitzberg E, Rudehill A, et al. The endothelin system in septic and endotoxin shock. Eur J Pharmacol 2000;407:1–15
    CrossRefPubMedWeb of Science
  76. ↵
    Sugiura M, Inagami T, Kon V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989;161:1220–27
    CrossRefPubMedWeb of Science
  77. ↵
    Bannan J, Visvanathan K, Zabriskie JB. Structure and function of streptococcal and staphylococcal superantigens in septic shock. Infect Dis Clin North Am 1999;13:387–96, ix
    CrossRefPubMedWeb of Science
  78. ↵
    Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995;8:411–26
    Abstract/FREE Full Text
  79. ↵
    Sriskandan S, Cohen J. Gram-positive sepsis: mechanisms and differences from gram-negative sepsis. Infect Dis Clin North Am 1999;13:397–412
    CrossRefPubMedWeb of Science
  80. ↵
    Halloran PF, Batiuk TD, Goes N, et al. Immunologic concepts. In: Stuart FP, Abecassis MM, DB K, eds. Organ Transplantation. 2nd ed. Georgetown, Tex: Landes Bioscience;2003 :1–44
  81. ↵
    Cerilli J, Brasile L, Galouzis T, et al. The vascular endothelial cell antigen system. Transplantation 1985;39:286–89
    PubMed
  82. ↵
    Immunity to tumors. In: Abbas AK, Lichtman AH, eds. Cellular and Molecular Immunology 5th ed. Philadelphia: Elsevier Saunders;2005;391–410
  83. ↵
    Starzl TE, Demetris AJ, Trucco M, et al. Cell migration, chimerism, and graft acceptance, with particular reference to the liver. In: Busuttil RW, Klintmalm G, eds. Transplantation of the Liver. Philadelphia: WB Saunders;1996 :274–87
  84. ↵
    Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996;93:705–08
    Abstract/FREE Full Text
  85. ↵
    Thomas MR, Williamson R, Craft I, et al. Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy. Lancet 1994;343:413–14
    PubMedWeb of Science
  86. ↵
    Holzgreve W, Ghezzi F, Di Naro E, et al. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 1998;91:669–72
    CrossRefPubMedWeb of Science
  87. ↵
    Smith A. Systemic sclerosis: etiology and pathogenesis. In: Hochbert MC, Silman AJ, Smolen JS, et al, eds. Rheumatology. 3rd ed. Edinburgh, UK: Mosby;2003 :1481–92
  88. ↵
    Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998;338:1186–91
    CrossRefPubMedWeb of Science
  89. ↵
    Nelson JL, Furst DE, Maloney S, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998;351:559–62
    CrossRefPubMedWeb of Science
  90. ↵
    Furst DE, Clements PJ, Graze P, et al. A syndrome resembling progressive systemic sclerosis after bone marrow transplantation: a model for scleroderma? Arthritis Rheum 1979;22:904–10
    PubMedWeb of Science
  91. ↵
    McCormick LL, Zhang Y, Tootell E, et al. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 1999;163:5693–99
    Abstract/FREE Full Text
  92. ↵
    Crow MK. Cellular immunity: systemic lupus erythematosus. In: Hochbert MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology. 3rd ed. Edinburgh, UK: Mosby;2003 :1347–58
  93. ↵
    Stone JH, Hoffman GS. Wegener's granulomatosis and lymphomatoid granulomatosis. In: Hochbert MC, Silman AJ, Smolen JS, et al, eds. Rheumatology. 3rd ed. Edinburgh, UK: Mosby;2003 :1624–34
  94. ↵
    Ito T, Sakai T, Inagawa S, et al. MR angiography of cerebral vasospasm in preeclampsia. AJNR Am J Neuroradiol 1995;16:1344–46
    Abstract
  95. Lin JT, Wang SJ, Fuh JL, et al. Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy. AJNR Am J Neuroradiol 2003;24:102–04
    Abstract/FREE Full Text
  96. ↵
    Shbarou RM, Chao NJ, Morgenlander JC. Cyclosporin A-related cerebral vasculopathy. Bone Marrow Transplant 2000;26:801–04
    CrossRefPubMed
  97. ↵
    Bartynski WS, Grabb BC, Zeigler Z, et al. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr 1997;21:872–80
    CrossRefPubMed
  98. ↵
    Kevil CG, Payne DK, Mire E, et al. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem 1998;273:15099–103
    Abstract/FREE Full Text
  99. Levy AP, Levy NS, Wegner S, et al. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995;270:13333–40
    Abstract/FREE Full Text
  100. ↵
    Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843–45
    CrossRefPubMedWeb of Science
  101. ↵
    Chavez JC, Agani F, Pichiule P, et al. Expression of hypoxia-inducible factor-1 alpha in the brain of rats during chronic hypoxia. J Appl Physiol 2000;89:1937–42
    Abstract/FREE Full Text
  102. ↵
    Schoch HJ, Fischer S, Marti HH. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 2002;125:2549–57
    Abstract/FREE Full Text
  103. ↵
    Sengar AR, Gupta RK, Dhanuka AK, et al. MR imaging, MR angiography, and MR spectroscopy of the brain in eclampsia. AJNR Am J Neuroradiol 1997;18:1485–90
    Abstract
  104. ↵
    Xu L, Fukumura D, Jain RK. Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway: mechanism of low pH-induced VEGF. J Biol Chem 2002;277:11368–74. Epub 2001 Dec 11
    Abstract/FREE Full Text
  105. ↵
    Weinberger MH. Hypertensive encephalopathy. In: Noseworthy JH, ed. Neurological Therapeutics: Principles and Practice. 2nd ed. Milton Park, Abington, Oxon, UK: Informa Healthcare;2006 :670–73
  106. ↵
    Thompson CB, June CH, Sullivan KM, et al. Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet 1984;2:1116–20
    PubMedWeb of Science
  107. ↵
    van den Bergh WM, Algra A, van Kooten F, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005;36:1011–15
    Abstract/FREE Full Text
  108. Belfort MA, Moise KJ Jr. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol 1992;167:661–66
    PubMedWeb of Science
  109. ↵
    Ram Z, Sadeh M, Shacked I, et al. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 1991;22:922–27
    Abstract/FREE Full Text
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 29 (6)
American Journal of Neuroradiology
Vol. 29, Issue 6
June 2008
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
W.S. Bartynski
Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema
American Journal of Neuroradiology Jun 2008, 29 (6) 1043-1049; DOI: 10.3174/ajnr.A0929

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema
W.S. Bartynski
American Journal of Neuroradiology Jun 2008, 29 (6) 1043-1049; DOI: 10.3174/ajnr.A0929
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • Current Popular Theory: Hypertension, Failed Autoregulation, Hyperperfusion
    • Early Original Theory: Vasoconstriction, Hypoperfusion, Ischemia
    • Conclusions
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Undiagnosed fibromuscular dysplasia in a deceased donor kidney transplant successfully treated with angioplasty
  • Posterior reversible encephalopathy syndrome (PRES): presentation, diagnosis and treatment
  • Posterior reversible encephalopathy syndrome
  • Posterior reversible encephalopathy syndrome associated with the use of chemotherapeutic agents: a rare complication after treatment with vinorelbine
  • Delayed Leukoencephalopathy: A Rare Complication after Coiling of Cerebral Aneurysms
  • Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome
  • Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement
  • Posterior reversible encephalopathy syndrome in an HIV-infected patient on antiretroviral treatment: what is the risk factor?
  • Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years?
  • Reversible brain lesion following growth hormone replacement therapy in an adolescent
  • Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES)
  • Clinical Reasoning: A young man with acute encephalopathy, loss of vision, and upper motor neuron signs
  • Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study
  • Posterior Reversible Encephalopathy Syndrome as an Overlooked Complication of Induced Hypertension for Cerebral Vasospasm: Systematic Review and Illustrative Case
  • Cytotoxic Edema in Posterior Reversible Encephalopathy Syndrome: Correlation of MRI Features with Serum Albumin Levels
  • Posterior reversible encephalopathy syndrome is not associated with mutations in aquaporin-4
  • Posterior Reversible Encephalopathy Syndrome in Patients With Cancer
  • What to see when you are looking at confusion: a review of the neuroimaging of acute encephalopathy
  • Hypertensive crisis: Reversible edema in leukoencephalopathy, retinopathy, now myelopathy?
  • Sinking skin flap syndrome in glioblastoma
  • Posterior reversible encephalopathy syndrome (PRES) in a patient with late postpartum eclampsia
  • Clinicopathologic and MRI Characteristics of Presumptive Hypertensive Encephalopathy in Two Cats and Two Dogs
  • Cerebral hyperperfusion syndrome: A novel presentation of internal carotid artery dissection
  • An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
  • Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient
  • The many faces of posterior reversible encephalopathy syndrome
  • Posterior Reversible Encephalopathy Syndrome: A Truly Treatable Neurologic Illness
  • Posterior reversible encephalopathy syndrome: the importance of early diagnosis
  • Posterior reversible encephalopathy syndrome mimicking a cerebral tumour
  • The posterior reversible encephalopathy syndrome in HIV infection
  • Detection of Microhemorrhage in Posterior Reversible Encephalopathy Syndrome Using Susceptibility-Weighted Imaging
  • Dr. Varaprasad and Dr. Agrawal reply
  • Reversible Posterior Leukoencephalopathy in a Venomous Snake (Bothrops asper) Bite Victim
  • Unusual Adverse Event With Vandetanib in Metastatic Medullary Thyroid Cancer
  • Dr. Varaprasad and Dr. Agrawal reply
  • Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus
  • Posterior Reversible Encephalopathy Syndrome: Increasing Recognition of an Important Clinical Entity in Young Patients with Systemic Lupus Erythematosus
  • Suspicious Neuroimaging Pattern of Thrombotic Microangiopathy
  • Type of Edema in Posterior Reversible Encephalopathy Syndrome Depends on Serum Albumin Levels: An MR Imaging Study in 28 Patients
  • Phase I Study of Vandetanib During and After Radiotherapy in Children With Diffuse Intrinsic Pontine Glioma
  • Cerebral vasomotor reactivity monitoring in posterior reversible encephalopathy syndrome
  • Influenza A Encephalopathy, Cerebral Vasculopathy, and Posterior Reversible Encephalopathy Syndrome: Combined Occurrence in a 3-Year-Old Child
  • Isolated Acute Nontraumatic Cortical Subarachnoid Hemorrhage
  • ENCEPHALITIS DURING INTERFERON BETA-1A TREATMENT IN A CHILD WITH OPTIC NEURITIS
  • ASYMPTOMATIC SPINAL CORD INVOLVEMENT IN POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
  • Reversible cerebral vasoconstriction syndrome
  • Hemorrhage in Posterior Reversible Encephalopathy Syndrome: Imaging and Clinical Features
  • Reversible posterior leukoencephalopathy syndrome caused by hanging
  • MR Imaging Findings of Medulla Oblongata Involvement in Posterior Reversible Encephalopathy Syndrome Secondary to Hypertension
  • Reversible Encephalopathy after Cardiac Transplantation: Histologic Evidence of Endothelial Activation, T-Cell Specific Trafficking, and Vascular Endothelial Growth Factor Expression
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • An Atlas of Neonatal Neurovascular Imaging Anatomy as Depicted with Microvascular Imaging: The Intracranial Arteries
  • An Atlas of Neonatal Neurovascular Imaging Anatomy as Depicted with Microvascular Imaging: The Intracranial Veins
  • Clinical Translation of Hyperpolarized 13C Metabolic Probes for Glioma Imaging
Show more Review Articles

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire